-
Featured
Novel Therapeutic May Prevent Mitral Valve Damage After Heart Attack
Damage to the mitral valve after heart attack leads to HF and death. Treatment with hypertension drug may reduce mitral valve scaring and stiffening.
-
Featured
Left Ventricular-Mitral Valve Ring Ratio May Predict Recurrent Mitral Regurgitation
Researchers found that a mismatch in left ventricular and mitral valve ring size can predict whether a patient is at a higher risk of recurrent mitral regurgitation after mitral valve repair.
-
Featured
Cardiac CT Mechanical Valve Prosthesis Dysfunction Diagnosis
A 27-year-old woman with history of type 1 truncus arteriosus presented with several months of progressive dyspnea for subspecialty ACHD care.
-
Review: Optimal Anticoagulation After Bioprosthetic Valve Replacement
Massachusetts General Hospital researchers review medical society guidelines about anticoagulation and antiplatelet therapy after bioprosthetic aortic and mitral valve replacement—and propose their own strategies.
-
Tricuspid Valve Repair and Tricuspid Valve Replacement Successfully Performed at Mass General
A tricuspid valve replacement and tricuspid valve repair–both involving catheter-based systems designed specifically for patients with tricuspid valve disease–have been successfully performed at Mass General.
-
Hospital PCI Volume Unrelated to Outcomes of Transcatheter Valve Replacement, Repair
The first study to examine whether hospital volume of percutaneous coronary interventions is associated with the outcomes of structural heart procedures found no association between the two metrics.
Valvular Heart Disease contributors
-
Jacob Dal-Bianco, MD
Cardiologist
Recent Article
Novel Therapeutic May Prevent Mitral Valve Damage After Heart Attack
-
Judy Wei-Ming Hung, MD
Director of the Echocardiography Lab, Division of Cardiology, Professor of Medicine, Harvard Medical School
Recent Article
Measuring Transvalvular Flow Rate Adds to Prognostication About Aortic Stenosis
-
Robert A. Levine, MD
Senior Physician, Cardiac Ultrasound Laboratory
Recent Article
Cilia Defects During Fetal Development Can Cause Mitral Valve Prolapse -
Serguei Melnitchouk, MD, MPH
Cardiac Surgeon, Co-Director, Heart Valve Program, Quality Director, Division of Cardiac Surgery
Recent Article
Review: Optimal Anticoagulation After Bioprosthetic Valve Replacement
-
Thoralf M. Sundt, MD
Chief, Division of Cardiac Surgery, Director, Corrigan Minehan Heart Center
Recent Article
Non–Vitamin K Antagonist Oral Anticoagulants Are Safe for Selected Patients with Postoperative AF
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.Resource links
